This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Title: The Innovations of Stephen S. Whitehead
Introduction
Stephen S. Whitehead is a notable inventor based in the United States, recognized for his contributions to the field of virology. His work primarily focuses on the development of mutations that are useful for attenuating dengue viruses and chimeric dengue viruses. This innovative approach aims to enhance the efficacy of dengue virus vaccines.
Latest Patents
Stephen S. Whitehead holds a patent for the "Development Of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses." This invention provides a flavivirus with a viral genome modified by the introduction of one or more mutations. The flavivirus may be attenuated and can exhibit phenotypes such as temperature sensitivity, host-cell restriction, or host-cell adaptation for improved replication. A comprehensive menu of mutations was developed to fine-tune the attenuation and growth characteristics of dengue virus vaccines.
Career Highlights
Stephen S. Whitehead is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has significantly contributed to the understanding and potential treatment of dengue viruses, showcasing his expertise in the field.
Collaborations
Stephen has collaborated with notable colleagues, including Joseph E. Blaney and Brian R. Murphy. Their combined efforts have advanced research in the area of dengue virus attenuation and vaccine development.
Conclusion
Stephen S. Whitehead's innovative work in the field of virology, particularly regarding dengue viruses, highlights his significant contributions to medical science. His research continues to pave the way for advancements in vaccine development and public health.